Cognos Therapeutics Inc
PrivateLast Round
Seed Round
May 21, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cognos Therapeutics Inc operates in Healthcare & Life Sciences and is based in Inglewood, California. It was founded in 2003.
Cognos Therapeutics Inc is a medical technology company developing the SINNAIS™, an implantable smart pump for targeted drug delivery to treat neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cognos Therapeutics Inc Comparables
Compare Cognos Therapeutics Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theracle | 87% | |
| Precision NeuroMed | 85% | |
| CraniUS Therapeutics | 84% |
For institutional investors. Book with your work email.
Cognos Therapeutics Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 21, 2026 | ||||
| Seed | Sep 30, 2021 | ||||
| Seed | Dec 14, 2020 | ||||
| Seed | May 17, 2018 | ||||
| Seed | Apr 8, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
$250K raised in Seed Round.
- Feb 24, 2025
Monthly visitors increased 72% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Cognos Therapeutics Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cognos Therapeutics Inc's valuation, stock price, and market status.
Is Cognos Therapeutics Inc a public or private company?
Cognos Therapeutics Inc is a private company.
What is the current stock price of Cognos Therapeutics Inc?
Cognos Therapeutics Inc is a private company, so its shares have no public market price. Caplight tracks Cognos Therapeutics Inc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cognos Therapeutics Inc worth (valuation)?
Valuation information for Cognos Therapeutics Inc is not publicly available.
Can I buy Cognos Therapeutics Inc stock?
Cognos Therapeutics Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cognos Therapeutics Inc's last funding round?
Cognos Therapeutics Inc's most recent funding round was Seed Round on May 21, 2026.
Who are the main investors in Cognos Therapeutics Inc?
Investor information for Cognos Therapeutics Inc is not publicly disclosed.
Will Cognos Therapeutics Inc IPO soon?
No public IPO plans have been announced for Cognos Therapeutics Inc.
How can I track Cognos Therapeutics Inc secondary market activity?
Caplight tracks bids, offers, and trades in Cognos Therapeutics Inc's shares on secondary markets.